Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.50 (1.03%)
Bid:
48.80
Ask:
49.00
Spread: 0.20 (0.41%)
Market Cap: £310.10m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

12 Dec 2024 14:59

RNS Number : 9142P
Marston's PLC
12 December 2024
 

12 December 2024

 

Marston's PLC (the "Company") - Notification of Transactions of Directors/Persons Discharging Managerial Responsibility

 

Marston's PLC (the "Company") announces that on 11 December 2024 the Director listed below exercised an award over ordinary shares in the Company under the Company's 2014 Long Term Incentive Plan, which had been granted on 12 December 2019. 

 

Director

Aggregate number of shares in respect of which LTIP Award exercised

 

Hayleigh Lupino

17,550

 

The Director also completed a separate acquisition of shares on 11 December 2024.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

Enquiries: Bethan Raybould, General Counsel and Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 Hayleigh Lupino

 

2

 

Reason for the notification

a)

 

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

 

Initial notification /Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Marston's PLC

 

b)

 

LEI

LEI no. 213800Q6RP3ZJ2CZR962

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 7.375p each

 

Identification code

ISIN GB00B1JQDM80

 

b)

 

Nature of the transaction

Exercise of award under the Long Term Incentive Plan

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

N/A

17,550

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a single transaction

 

n/a single transaction

 

e)

 

Date of the transaction

2024-12-11

 

f)

 

Place of the transaction

Outside a trading venue

 

 

5

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 7.375p each

 

Identification code

ISIN GB00B1JQDM80

 

b)

 

Nature of the transaction

Purchase of shares by Hayleigh Lupino

 

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

£0.434838

45,736

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a single transaction

 

n/a single transaction

 

e)

 

Date of the transaction

2024-12-11

 

f)

 

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALAAFSXLFFA
Date   Source Headline
26th Jun 20232:23 pmRNSDirector/PDMR Shareholding
26th Jun 20231:08 pmRNSDirector/PDMR Shareholding
25th May 20238:16 amRNSDirector/PDMR Shareholding
24th May 20238:48 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 1 APRIL 2023
31st Mar 20237:00 amRNSAmendment and extension of debt facilities
22nd Mar 202310:19 amRNSHolding(s) in Company
24th Jan 20232:01 pmRNSResult of AGM
24th Jan 20237:00 amRNSTrading for the 16-week period to 21 January 2023
10th Jan 20233:07 pmRNSBlock listing Interim Review
6th Jan 20233:11 pmRNSHolding(s) in Company
3rd Jan 20239:42 amRNSHolding(s) in Company
21st Dec 20225:05 pmRNSConfirmation of Covenant Amendments
21st Dec 20222:34 pmRNSAnnual Financial Report
14th Dec 20229:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSPreliminary Results for 52 weeks ended 1 Oct 2022
5th Dec 202212:31 pmRNSConfirmation of Final Results announcement date
30th Nov 202210:46 amRNSHolding(s) in Company
28th Nov 202212:55 pmRNSChange to Final Results date and update on trading
28th Nov 20229:59 amRNSHolding(s) in Company
25th Nov 202212:04 pmRNSHolding(s) in Company
17th Nov 20229:14 amRNSHolding(s) in Company
17th Nov 20227:09 amRNSDirector Declaration re: New Directorship
10th Nov 202210:47 amRNSHolding(s) in Company
9th Nov 20228:15 amRNSHolding(s) in Company
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSTrading update for the 52 weeks to 1 October 2022
6th Oct 20229:31 amRNSCorrection re Holding(s) in Company
5th Oct 202212:15 pmRNSHolding(s) in Company
12th Sep 20229:43 amRNSDirector/PDMR Shareholding
5th Sep 202212:27 pmRNSDirector/PDMR Shareholding
2nd Sep 202210:14 amRNSDirector/PDMR Shareholding
31st Aug 20222:51 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading update for the 42 weeks to 23 July 2022
11th Jul 202212:03 pmRNSBlock listing Interim Review
7th Jul 20229:55 amRNSHolding(s) in Company
29th Jun 20228:45 amRNSDirector/PDMR Shareholding
13th Jun 20228:30 amRNSDirector/PDMR Shareholding
30th May 20222:14 pmRNSHolding(s) in Company
25th May 20228:54 amRNSHolding(s) in Company
20th May 202210:15 amRNSDirector/PDMR Shareholding
19th May 20227:00 amRNSInvestor Meet Company Presentation
18th May 20227:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 2 APRIL 2022
5th Apr 202212:39 pmRNSHolding(s) in Company
30th Mar 20228:28 amRNSDirector/PDMR Shareholding
28th Mar 20229:49 amRNSHolding(s) in Company
17th Mar 202210:18 amRNSHolding(s) in Company
8th Mar 202210:06 amRNSHolding(s) in Company
7th Mar 20227:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.